All Stories

  1. Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews
  2. Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia
  3. Switching antipsychotics: imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats
  4. New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine
  5. P.1.009 Effects of caffeine, nicotine and their combination with haloperidol on PSD molecules: relevance to psychiatric diseases
  6. Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones
  7. A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder.
  8. Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics
  9. D-aspartate dysregulation in Ddo−/− mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum
  10. Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials
  11. C.14.02 Second witness – impact on brain architecture
  12. Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism
  13. Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice
  14. Increased Signaling via Adenosine A1 Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a
  15. Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2)
  16. Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder
  17. Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: Insights for psychosis treatment
  18. A Role for D-aspartate Oxidase in Schizophrenia and in Schizophrenia-related Symptoms Induced by Phencyclidine in Mice.
  19. Worse Comes to Worst in Schizophrenia: Treatment Resistant Schizophrenia Patients Show Greater Impairment in Functional Milestones of Everyday Living Compared to Other Psychiatric Disabling Conditions
  20. A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice
  21. Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression
  22. MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective
  23. P.3.c.008 Immediate early and constitutive genes expression in antipsychotic switching paradigm: from clinical practice to animal model
  24. Regulation of postsynaptic plasticity genes' expression and topography by sustained dopamine perturbation and modulation by acute memantine: Relevance to schizophrenia
  25. Towards a framework for treatment effectiveness in schizophrenia
  26. The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment
  27. The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico- Subcortical Regions
  28. Poster #T100 MINOCYCLINE ADD-ON TO HALOPERIDOL BLUNTS HALOPERIDOL-MEDIATED EXPRESSION OF EARLY GENES IMPLICATED IN GLUTAMATERGIC NEUROTRANSMISSION IN BOTH VEHICLE AND KETAMINE-TREATED RATS
  29. Poster #M252 PATIENTS' OPINIONS ON KEY ISSUES OF PSYCHOSOCIAL FUNCTIONING AMONG NON-PSYCHOTICS PSYCHOTIC RESPONDERS AND NON-RESPONDERS: CORRELATION WITH CLINICAL VARIABLES AND SYMPTOM DOMAINS RELEVANT TO REMISSION FROM PSYCHOSIS
  30. Poster #S257 TOUCHING BY HAND HOW PSYCHOTIC FEATURES TRANSLATE INTO WORSE LIFE CONDITIONS: THE RELATION OF KEY PSYCHOSOCIAL ISSUES WITH CLINICAL VARIABLES IN NON-PSYCHOTIC, PSYCHOTIC RESPONDER, AND PSYCHOTIC NON-RESPONDER PATIENTS
  31. The emerging role of dopamine–glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment
  32. Patients with Poor Response to Antipsychotics Have a More Severe Pattern of Frontal Atrophy: A Voxel-Based Morphometry Study of Treatment Resistance in Schizophrenia
  33. EPA-1116 - Obesity affects cognitive performances even in the absence of obvious psychopathological alterations. a comparison with schizophrenia subjects and non-affected controls
  34. Efficacy and Clinical Determinants of Antipsychotic Polypharmacy in Psychotic Patients Experiencing an Acute Relapse and Admitted to Hospital Stay: Results from a Cross-Sectional and a Subsequent Longitudinal Pilot Study
  35. EPA-1118 - Knowledge of the illness and its relations with quality of life, social functioning, cognitive performances, and adherence in psychotic patients: Toward effectiveness-focused interventions
  36. Differential Adaptive Changes in Dopaminergic System by Acute vs. Subchronic Ketamine: Relevance for Psychosis Pathophysiology and Treatment
  37. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: Correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses
  38. Imaging brain gene expression profiles by antipsychotics: Region-specific action of amisulpride on postsynaptic density transcripts compared to haloperidol
  39. Affective temperaments are associated with specific clusters of symptoms and psychopathology: A cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse
  40. P.1.g.054 Gene-expression imaging by N-methyl-D-aspartate receptor antagonists: implications for dopamine–glutamate interplay in psychosis
  41. Intracellular pathways of antipsychotic combined therapies: Implication for psychiatric disorders treatment
  42. Decreased levels of d-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia
  43. Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches
  44. Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment
  45. The Role of Intranasal Oxytocin in the Treatment of Patients with Schizophrenia: A Systematic Review
  46. 2251 – Cortical and subcortical gene-expression imaging by different n-methyl-daspartate receptor (nmda-r) antagonists at glutammatergic synapses: implications for dopamine-glutamate interplay in psychoses
  47. Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins
  48. P.3.c.043 Resistance to antipsychotics is associated with higher cognitive impairment compared to non-resistant schizophrenia
  49. Scaffolding Proteins of the Post-synaptic Density Contribute to Synaptic Plasticity by Regulating Receptor Localization and Distribution: Relevance for Neuropsychiatric Diseases
  50. Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance
  51. Calcium-Dependent Networks in Dopamine–Glutamate Interaction: The Role of Postsynaptic Scaffolding Proteins
  52. Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor
  53. The expression of genes involved in glucose metabolism is affected by N-methyl-D-aspartate receptor antagonism: A putative link between metabolism and an animal model of psychosis
  54. Clozapine impairs insulin action by up-regulating AKT phosphorylation and Ped/Pea-15 protein abundance
  55. Group 1 metabotropic glutamate receptors and schizophrenia
  56. Striatal expression of Homer1a is affected by genotype but not dystonic phenotype of tottering mice: A model of spontaneously occurring motor disturbances
  57. Weight Gain, Schizophrenia and Antipsychotics: New Findings from Animal Model and Pharmacogenomic Studies
  58. The acute and chronic effects of combined antipsychotic–mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes
  59. P03-62 - Opioidergic system and N-methyl D-aspartate receptor (NMDA-R) hypofunction: Translational implications for the pathophysiology of psychosis and drug addiction
  60. Haloperidol induces higher Homer1a expression than risperidone, olanzapine and sulpiride in striatal sub-regions
  61. Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first- and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes
  62. Dopamine receptor subtypes contribution to Homer1a induction: Insights into antipsychotic molecular action
  63. Antipsychotic and antidepressant co-treatment: Effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders
  64. HOMER1 Promoter Analysis in Parkinson’s Disease: Association Study with Psychotic Symptoms
  65. Association of antipsychotic induced weight gain and body mass index with GNB3 gene: A meta-analysis
  66. Analysis of Posttransplant Diabetes Mellitus Prevalence in a Population of Kidney Transplant Recipients
  67. P.1.17 Topographical and temporal distribution of Homer1a expression is correlated to antipsychotics dopaminergic profile
  68. Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: Implication for glutamatergic postsynaptic density in antipsychotics action
  69. Ketamine-related expression of glutamatergic postsynaptic density genes: Possible implications in psychosis
  70. Prediction of antipsychotics gene targets by integration of genomic, evolutionary, and gene expression data
  71. Trp64Arg beta3 adrenergic polymorphism in antipsychotic-induced weight gain and obesity: A meta-analysis
  72. Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis
  73. Differential expression ofHomer 1 gene by acute and chronic administration of antipsychotics and dopamine transporter inhibitors in the rat forebrain
  74. Ferrous-Citrate Complex and Nigral Degeneration: Evidence for Free-radical Formation and Lipid Peroxidationa
  75. Long-Term Outcome of Renal Transplantation From Marginal Donors
  76. Gene–gene interaction between MAOA and COMT in suicidal behavior: Analysis in schizophrenia
  77. Association study between the novel functional polymorphism of the serotonin transporter gene and suicidal behaviour in schizophrenia
  78. Dopamine-Glutamate Interaction and Antipsychotics Mechanism of Action: Implication for New Pharmacological Strategies in Psychosis
  79. Permanent Focal Brain Ischemia Induces Isoform-Dependent Changes in the Pattern of Na+/Ca2+ Exchanger Gene Expression in the Ischemic Core, Periinfarct Area, and Intact Brain Regions
  80. Cytomegalovirus Infection With Multiple Colonic Perforations in a Renal Transplant Recipient
  81. Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation
  82. Postsynaptic density scaffolding proteins at excitatory synapse and disorders of synaptic plasticity: implications for human behavior pathologies
  83. Method for quantitative in situ hybridization histochemistry and image analysis applied for Homer1a gene expression in rat brain
  84. The forgotten therapy: Depot neuroleptics in the era of atypical antipsychotics, a community based study
  85. Antipsychotics with different D2 dopamine receptor potency affect differently the postsynaptic density protein homer at glutamatergic metabotropic synapse
  86. Selective regulation of presynaptic Calcium/Calmodulin-Dependent protein kinase II by psychotropic drugs
  87. Decreased gene expression of calretinin and ryanodine receptor type 1 in tottering mice
  88. Acute administration of antipsychotics modulates Homer striatal gene expression differentially
  89. NMDA receptor hypofunction: Cortical and subcortical CaMKII mRNA gene expression
  90. Postsynaptic density protein gene expression after typical or atypical antipsychotics administration
  91. Simian virus-40 large-T antigen binds p53 in human mesotheliomas
  92. Opioidergic and dopaminergic gene expression in the caudate-putamen and accumbens of the mutant mouse, tottering (tg/tg)
  93. Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous Infusion
  94. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
  95. In vivo estimates of synaptic dopamine concentrations with 11C-raclopride/pet: A direct test of the dopamine hypothesis
  96. Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus
  97. Dopaminergic and peptidergic mRNA levels in juvenile rat brain after prenatal cocaine treatment
  98. Dopaminergic regulation of epileptic activity
  99. Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia
  100. Plasma HVA in schizophreniform disorder and chronic schizophrenia
  101. Survey on Schizophrenia